Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
One of the main problems of nasopharyngeal carcinoma treatment is the high incidence regional and distant failures. The method of choice in the first line therapy for the primarily diagnosed nasopharyngeal carcinoma is chemoradiotherapy with poor success rate. The main etiological factor in the occu...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-11-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849403865066110976 |
|---|---|
| author | D. A. Miroshnichenko A. P. Polyakov A. V. Mordovsky |
| author_facet | D. A. Miroshnichenko A. P. Polyakov A. V. Mordovsky |
| author_sort | D. A. Miroshnichenko |
| collection | DOAJ |
| description | One of the main problems of nasopharyngeal carcinoma treatment is the high incidence regional and distant failures. The method of choice in the first line therapy for the primarily diagnosed nasopharyngeal carcinoma is chemoradiotherapy with poor success rate. The main etiological factor in the occurrence of nasopharyngeal carcinoma is the Epstein–Barr virus, which DNA’s copies could be detected in blood samples in patients with nasopharyngeal carcinoma, which may indicate tumor activity. The indicators of these titers reach different values depending on the stage of the tumor process, the presence of distant metastases, individual patient parameters, and the tumor response to the therapy. Given the high specificity of this biological marker, it is necessary to consider the possibility of its use as a prognostic indicator for assessing the success of the selected method of conservative treatment, as well as assessing the prognosis. |
| format | Article |
| id | doaj-art-a6dbd627770a419bb54af003fc7a9e32 |
| institution | Kabale University |
| issn | 2222-1468 2411-4634 |
| language | Russian |
| publishDate | 2020-11-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли головы и шеи |
| spelling | doaj-art-a6dbd627770a419bb54af003fc7a9e322025-08-20T03:37:09ZrusABV-pressОпухоли головы и шеи2222-14682411-46342020-11-01103818910.17650/2222-1468-2020-10-3-81-89408Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)D. A. Miroshnichenko0A. P. Polyakov1A. V. Mordovsky2I.M. Sechenov First Moscow State Medical University, Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of RussiaP.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of RussiaOne of the main problems of nasopharyngeal carcinoma treatment is the high incidence regional and distant failures. The method of choice in the first line therapy for the primarily diagnosed nasopharyngeal carcinoma is chemoradiotherapy with poor success rate. The main etiological factor in the occurrence of nasopharyngeal carcinoma is the Epstein–Barr virus, which DNA’s copies could be detected in blood samples in patients with nasopharyngeal carcinoma, which may indicate tumor activity. The indicators of these titers reach different values depending on the stage of the tumor process, the presence of distant metastases, individual patient parameters, and the tumor response to the therapy. Given the high specificity of this biological marker, it is necessary to consider the possibility of its use as a prognostic indicator for assessing the success of the selected method of conservative treatment, as well as assessing the prognosis.https://ogsh.abvpress.ru/jour/article/view/564nasopharyngeal carcinomaepstein–barr viruschemoradiotherapy |
| spellingShingle | D. A. Miroshnichenko A. P. Polyakov A. V. Mordovsky Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review) Опухоли головы и шеи nasopharyngeal carcinoma epstein–barr virus chemoradiotherapy |
| title | Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review) |
| title_full | Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review) |
| title_fullStr | Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review) |
| title_full_unstemmed | Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review) |
| title_short | Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review) |
| title_sort | monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining epstein barr virus dna titers in blood plasma review |
| topic | nasopharyngeal carcinoma epstein–barr virus chemoradiotherapy |
| url | https://ogsh.abvpress.ru/jour/article/view/564 |
| work_keys_str_mv | AT damiroshnichenko monitoringtheefficacyofconservativetreatmentofnasopharyngealcarcinomabyexaminingepsteinbarrvirusdnatitersinbloodplasmareview AT appolyakov monitoringtheefficacyofconservativetreatmentofnasopharyngealcarcinomabyexaminingepsteinbarrvirusdnatitersinbloodplasmareview AT avmordovsky monitoringtheefficacyofconservativetreatmentofnasopharyngealcarcinomabyexaminingepsteinbarrvirusdnatitersinbloodplasmareview |